Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tongxinluo combined with statins for carotid plaque
ChiCTR-IPR-14005367Phase 4Recruiting
- Sponsor
- Shandong Provincial Qianfoshan Hospital
- Start
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Tongxinluo in carotid atheroma (CAS), Carotid artery disease (CAD) and atherosclerosis (3 arms), sponsored by Shandong Provincial Qianfoshan Hospital. Primary endpoints: Intima-media thickness and Flow-mediated dilation percentage. Started Nov 2014; status: recruiting.
02
Drugs
Tongxinluo
03
Conditions
carotid atheroma (CAS)Carotid artery disease (CAD)atherosclerosis
Beyond the preview
Go deeper on ChiCTR-IPR-14005367.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-14005367.